69 results
Page 2 of 4
8-K/A
ul34n1wjqb0p5rgx7wa
16 Nov 21
Regulation FD Disclosure
5:29pm
8-K
EX-99.1
iojjchkyw4pev6llepcf
10 Nov 21
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
1:08pm
DEF 14A
9c2ul9vjuhi 59sshdf
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
1cct2cq4
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
eslem
24 Sep 21
Annual report
7:31am
10-K
mtibuuk
24 Sep 21
Annual report
7:31am
424B3
vgj7agcyrfat
22 Jul 21
Prospectus supplement
10:27am
424B3
m8uugn4hrw914j
16 Mar 21
Prospectus supplement
12:00am
S-8
EX-4.2
87d2m5lcbcsw1ug6z45
5 Mar 21
Registration of securities for employees
12:54pm
10-Q
EX-3.1
j7x8rn 7vbmhm
17 Dec 20
Quarterly report
12:00am
424B4
g83u3u
13 Nov 20
Prospectus supplement with pricing info
8:52pm